Article Details

Metsera: $290 Million Secured To Develop Medicines For Obesity And Metabolic Diseases

Retrieved on: 2024-04-21 00:27:43

Tags for this article:

Click the tags to see associated articles and topics

Metsera: $290 Million Secured To Develop Medicines For Obesity And Metabolic Diseases. View article details on hiswai:

Excerpt

Metsera, a clinical-stage biopharmaceutical company advancing the next ... biopharma. We have assembled a portfolio of long-acting injectable and ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo